Notification of discontinuation of an agreed PIP decision
Submitted by Anonymous (not verified) on 19 December 2023 - 10:29
Notification of discontinuation of an agreed PIP decision
Scientific advice and protocol assistance adopted during the CHMP meeting 11-14 December 2023
Submitted by Anonymous (not verified) on 19 December 2023 - 10:13
Scientific advice and protocol assistance adopted during the CHMP meeting 11-14 December 2023
Member states contact points for translations review
Submitted by Anonymous (not verified) on 19 December 2023 - 10:12
Member states contact points for translations review
Scientific and technical recommendations: Veterinary Medicines Regulation
Submitted by Anonymous (not verified) on 19 December 2023 - 10:00
Scientific and technical recommendations: Veterinary Medicines Regulation
Draft guideline on the evaluation of the benefit-risk balance of veterinary medicinal products
Submitted by Anonymous (not verified) on 18 December 2023 - 16:20
Draft guideline on the evaluation of the benefit-risk balance of veterinary medicinal products
Human medicines European public assessment report (EPAR): Feraccru, ferric maltol, Date of authorisation: 18/02/2016, Revision: 18, Status: Authorised
Submitted by Anonymous (not verified) on 18 December 2023 - 15:04
Human medicines European public assessment report (EPAR): Feraccru, ferric maltol, Date of authorisation: 18/02/2016, Revision: 18, Status: Authorised
Comirnaty : Periodic safety update report assessment 19 June 2022 to 18 December 2022
Submitted by Anonymous (not verified) on 18 December 2023 - 14:37
Comirnaty : Periodic safety update report assessment 19 June 2022 to 18 December 2022
Vaxzevria: Periodic safety update report assessment 29 December 2021 to 28 June 2022
Submitted by Anonymous (not verified) on 18 December 2023 - 14:24
Vaxzevria: Periodic safety update report assessment 29 December 2021 to 28 June 2022
List of acronyms and abbreviations used in CVMP agenda and minutes
Submitted by Anonymous (not verified) on 18 December 2023 - 14:15
List of acronyms and abbreviations used in CVMP agenda and minutes
Regulatory requirements for the development of medicinal products for Acute Kidney Injury (AKI) - Scientific guideline
Submitted by Anonymous (not verified) on 18 December 2023 - 13:42
Regulatory requirements for the development of medicinal products for Acute Kidney Injury (AKI) - Scientific guideline